Attachment 1 HT940825Q0007.pdf

SEE ADDENDUM

(No Collect Calls)

HT940825Q0007 30-May-2025

b. TELEPHONE NUMBER

210-269-4696

8. OFFER DUE DATE/LOCAL TIME

01:00 PM 16 Jun 2025

5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

AUTHORIZED FOR LOCAL REPRODUCTION

PREVIOUS EDITION IS NOT USABLE

STANDARD FORM 1449 (REV. 2/2012)

Prescribed by GSA – FAR (48 CFR) 53.212

(TYPE OR PRINT)

(SIGNATURE OF CONTRACTING OFFICER)

ADDENDA X ARE

26. TOTAL AWARD AMOUNT (For Gov t. Use Only )

23.

CODE 10. THIS ACQUISITION IS

SUCH ADDRESS IN OFFER

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT

BELOW IS CHECKED

TELEPHONE NO.

HT94089. ISSUED BY

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a. UNLESS BLOCK

7. FOR SOLICITATION

INFORMATION CALL:

a. NAME

DAVID K ERPELDING

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NUMBER

(TYPE OR PRINT)

30b. NAME AND TITLE OF SIGNER 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a.UNITED STATES OF AMERICA

1 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1. 52.212-4. FAR 52.212-3. 52.212-5 ARE ATTACHED.X

25. ACCOUNTING AND APPROPRIATION DATA

1. REQUISITION NUMBER

20.

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED.

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, AND 30

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS

ARE NOT ATTACHED

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

SET FORTH HEREIN, IS ACCEPTED AS TO ITEMS:

. YOUR OFFER ON SOLICITATION

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN

% FOR:SET ASIDE:UNRESTRICTED ORX

SMALL BUSINESS

17a.CONTRACTOR/ CODE FACILITY

OFFEROR CODE

DHA CONTRACTING OFFICE SA HT9408

7800 W IH-10

STE 235

SAN ANTONIO TX 78230

18a. PAYMENT WILL BE MADE BY CODE

RATED ORDER UNDER

DPAS (15 CFR 700)

13a. THIS CONTRACT IS A

13b. RATING

CODE15. DELIVER TO CODE F2J4PC 16. ADMINISTERED BY

12. DISCOUNT TERMS11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

14. METHOD OF SOLICITATION

RFQ IFB RFPX

PROFESSIONAL CONTRACTS MEDICAL

LEN VAN SITTERT

AF BPN NO MILSBILLS PROCESSES

301 FISHER ST RM 1A132 BLDG 468 5TH

KEESLER AFB MS

TEL: 228-376-5000 FAX:

FAX:

TEL: SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

8(A)

HUBZONE SMALL

BUSINESS

SIZE STANDARD:

1,250

NAICS:

325413

X

OFFER DATED

29. AWARD OF CONTRACT: REF.

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND

EMAIL:

TEL:

31c. DATE SIGNED

SEE SCHEDULE

SCHEDULE OF SUPPLIES/ SERVICESITEM NO. QUANTITY UNIT UNIT PRICE AMOUNT

24.22.21.19.

WOMEN-OWNED SMALL BUSINESS (WOSB)

ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

32g. E-MAIL OF AUTHORIZED GOVERNMENT REPRESENTATIVE

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS

(CONTINUED)

PAGE 2 OF51

ACCEPTED, AND CONFORMS TO THE CONTRACT, EXCEPT AS NOTED: ______________________________________________________

32a. QUANTITY IN COLUMN 21 HAS BEEN

RECEIVED INSPECTED

32b. SIGNATURE OF AUTHORIZED GOVERNMENT

REPRESENTATIVE

32c. DATE 32d. PRINTED NAME AND TITLE OF AUTHORIZED GOVERNMENT

REPRESENTATIVE

32e. MAILING ADDRESS OF AUTHORIZED GOVERNMENT REPRESENTATIVE 32f . TELEPHONE NUMBER OF AUTHORIZED GOVERNMENT REPRESENTATIVE

37. CHECK NUMBER

FINALPARTIALCOMPLETE

36. PAYMENT35. AMOUNT VERIFIED

CORRECT FOR

34. VOUCHER NUMBER

FINAL

33. SHIP NUMBER

PARTIAL

38. S/R ACCOUNT NUMBER 39. S/R VOUCHER NUMBER 40. PAID BY

41a. I CERTIFY THIS ACCOUNT IS CORRECT AND PROPER FOR PAYMENT

41b. SIGNATURE AND TITLE OF CERTIFYING OFFICER 41c. DATE

42a. RECEIVED BY (Print)

42b. RECEIVED AT (Location)

42c. DATE REC'D (YY/MM/DD) 42d. TOTAL CONTAINERS

STANDARD FORM 1449 (REV. 2/2012) BACK

Prescribed by GSA – FAR (48 CFR) 53.212

AUTHORIZED FOR LOCAL REPRODUCTION

PREVIOUS EDITION IS NOT USABLE

SEE SCHEDULE

20.

SCHEDULE OF SUPPLIES/ SERVICES

21.

QUANTITY UNIT

22. 23.

UNIT PRICE

24.

AMOUNT

19.

ITEM NO.

HT940825Q0007

Section SF 1449 - CONTINUATION SHEET

STATEMENT OF OBJECTIVES

STATEMENT OF OBJECTIVES

The Keesler Medical Center at Keesler AFB, Mississippi requires two (2) identical and completely separate Coagulation analyzers. The successful offeror shall furnish all equipment, to include instrument installation, set-up, equipment validation (along with the associated supplies and labor), reagents, controls, and any necessary services (e.g., maintenance of furnished equipment) to Keesler Medical Center, Keesler AFB, MS for the purpose of Coagulation testing. This requirement will be met via equipment rental/lease or on a Cost Per Reportable Result (CPRR) basis. The requirement must include reagents to perform 4,000 Prothrombin time (PT) assays, 3,000 Activated Partial Thrombin time (aPTT or PTT) assays, 600 d-dimer assays, and 150 fibrinogen assays per year. In addition, yearly lot to lot conversion performed by a company specialist shall be provided in pricing. All equipment and reagents shall be supplied and serviced through the Vendor to include all parts, equipment, supplies, and other services required to ensure Keesler Medical Center is able to meet its objectives as listed herein. Equipment and associated peripherals must be delivered in such a time that installation, set-up and validations are completed and approved by the Laboratory Director to begin patient testing by the start of the base year of the period of performance. In addition, the Contractor must have an approved authority to operate (ATO) prior to use and any subsequent billing. ATO approval must be maintained and valid through the life of the contract.

Period of Performance:

Base: 1 October 2025 – 30 September 2026 Option 1: 1 October 2026 – 30 September 2027 Option 2: 1 October 2027 – 30 September 2028 Option 3: 1 October 2028 – 30 September 2029 Option 4: 1 October 2029 – 30 September 2030

1. Authorization to Operate (ATO) (Subfactor 1A)

1.1. Analyzers must have a bi-directional interface that can connect to and be fully interoperable with the laboratory information system and have an approved ATO as listed on CSTAR (https://info.health.mil/apps/HIT/cstar/Pages/Systems.aspx) prior to award. ATO approval must be maintained and valid through the life of the contract.

1.2. Middleware must have an approved ATO prior to use and any subsequent billing, and approval must be maintained and valid through the life of the contract.

1.3. Each interface shall allow for recognition and interpretation of MHS Genesis generated bar-code labels on all sample tube types. Connectivity between the Vendor instrument systems and middleware to each LIS will be required at varying times during the contracted period of performance. Location: 81MDTS/SGQC Clinical Laboratory, Keesler Medical Center, Keesler Air Force Base, MS.

2. Instruments/Equipment and Reagents/Consumables (Subfactor 1B).

2.1. Instruments/Equipment shall meet the following minimum requirements:

2.1.1. Instruments must be Food and Drug Administration (FDA) approved for testing to PT and PTT, D-dimer, and Fibrinogen. D-dimer must also be FDA approved for exclusion of deep venous thrombosis (DVT) and pulmonary embolism (PE) when used in combination with a pretest probability (PTP) score, without further imaging studies.

2.1.3. Each analyzer must automatically calculate INR (international normalization ratio) and included with each PT result.

2.1.4. Each analyzer must be fully automated.

2.1.5. Each analyzer must have a reagent bar-code identification system containing the lot number, expiration date, and unique identification code.

2.1.6. Users must be able to program on board user defined decision rules according to laboratory needs. Any additional software required to meet these requirements must be included in the offer price.

2.1.7. Each analyzer must have a cap piercing needle.

2.1.8. Each analyzer must automatically perform on-board dilutions when needed.

2.1.9. Each instrument must be tabletop and no larger than 68” in width (this includes any operating systems that sit beside the analyzer), 36” in height, and 34” in depth.

2.1.10 Instruments must be able to interrupt routine processing for STAT sample processing with minimal delay from order to aspiration.

2.1.11. Must be able to submit monthly quality control (QC) for peer group comparison.

2.1.12. Instrument must have on-board QC program with the following characteristics: Levy-Jennings charts, individual data point accumulation and cumulative QC data information, such as, standard deviation, coefficient of variation and mean for each test.

2.1.13. Instruments must audibly and visually alert user when QC is out of range and must be able to halt testing and /or print an alert on patient reports when quality control (QC) has not been performed or is out of range.

2.1.14. Instruments must be capable of audibly notifying the end user when reagents need to be replaced, and errors are detected.

2.1.15. Each instrument must have its own on-board waste container. No drain available for waste.

2.1.16. Instruments must have onboard rules for auto-verification.

2.1.17. Instruments must have the ability to detect insufficient sample volumes.

2.1.17.1 Instruments must have the ability/technology to detect and eliminate interference from lipemia, icterus and hemolysis, preventing recollections and delays in care for emergent and critical care patients.

2.1.18 All instruments and testing must be set up and validated in compliance with Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations and College of American Pathologist (CAP) standards.

2.1.19. The entire system must be independent of remote connections (internet, cloud, etc.) to be functional and serviceable.

2.1.20. Medical Technicians shall have the ability to walk away without any negative impact during the operational running of cycle.

2.1.21. Peripherals shall include at a minimum; Instrument stands (as needed), uninterruptable power sources (UPSs), electrical line conditioners, as required, instrument-specific computer terminals/CPUs, keyboards, computer mouse; Printers shall include at a minimum, initial toner for each as needed, and other equipment where required.

2.2. Reagents/Consumables.

2.2.1. The Vendor will include all reagents, controls and consumables in the contract. The requirement must include reagents to perform 4,000 Prothrombin time (PT) assays, 3,000 Activated Partial Thrombin time (aPTT or PTT) assays, 600 d-dimer assays, and 150 fibrinogen assays annually for 5 years (base plus 4 one-year options).

2.2.2. In determining reagent requirements, the Vendor shall consider requirements for routine quality control runs, routine calibration, periodic calibration/calibration verification in accordance with departmental policy and troubleshooting of out-of-control assays when calculating the yearly requirements.

2.2.3. PT, PTT, D-dimer and Fibrinogen reagents must be pre-calibrated. If not, calibration must be included in TSS/CAS (Technical Support Specialist/Clinical Application Specialist) performed lot conversion and reagent lot numbers must be sequestered.

2.2.4. For applicable tests, (PT, PTT, and fibrinogen) the company must be able to provide a TSS/CSS (Technical Support Specialist/Clinical Application Specialist) to perform yearly lot conversions to include normal range verification studies and sequester reagents that require lot conversions for each contract year.

2.2.5. Sequestered lots of reagent and quality control (QC) must have a shelf life that is 18 months or more.

3. Service and Maintenance (Subfactor 1C). The Vendor shall meet the following service and maintenance requirements.

3.1. Preventative maintenance and 24/7 technical support included with service contract along with all replacement parts, supplies and labor. Response to service needs provided not later than 24 hours and resolution not later than 48 hours (local service personnel preferred) from report of service need or receipt of replacement parts within standard business hours (5 days, 8 hours). If both analyzers are down, service personnel must be on-site within 4 hours of initial notification.

3.2. Service contract shall provide all personnel, equipment, tools, materials, supervision, parts, transportation, and other items and services necessary to perform all required repairs and scheduled preventive maintenance/safety inspections and calibrations of equipment. The performance of scheduled periodic preventive maintenance, safety checks, and calibrations that are not normally performed at the operator level shall be performed by Vendor service personnel in accordance with requirements as specified in the Vendor’s instrument maintenance manual.

Completion of analyzer installation will establish time-zero for determining the time frame for performance of periodic services.

3.3. Any service technician provided by the Vendor shall adhere to all required reporting procedures for Keesler Air Force Base.

3.4. In all cases, the Vendor shall provide all reagents, calibrators, controls, and any other materials necessary to troubleshoot instrument failure. Replacement parts used, as necessary, claimed from local operator-level maintenance kits as well as any reagents that may have been used shall be replaced at no cost by the Vendor.

3.5. If an analyzer move is deemed necessary, the Vendor shall relocate/revalidate any instrument if requested by the Government at no additional cost.

3.6. Vendor shall provide product service and support to include updates to operational software throughout the life cycle of the equipment.

3.7. Operator level daily maintenance must be minimal and take less than approximately 10 minutes daily.

4. Training (Subfactor 1D).

4.1. The Vendor shall provide the following training at no additional cost to the Government:

4.1.1. Initial training (upon award) for two (2) key operators including lodging (hotel, rental car), per diem, and travel (airfare) expenses to/from Keesler AFB, hotel, and training location (offsite location). Additional training, upon request, for one operator per year per instrument (lodging (hotel), per diem, and travel (airfare, rental car) expenses included to/from Keesler AFB, hotel, and training location). Alternative training delivery (i.e., distance training), if determined by the Government customer to be of equivalent quality, may be entertained in lieu of offsite, in-person training for non-initial training.

4.1.2 All training shall include basic analyzer operation, troubleshooting procedures, performance of operator level periodic preventive maintenance procedures, and the use of any data management/quality control software.

5. Delivery and Installation (Subfactor 1E).

5.1. All systems shall be delivered to the appropriate location indicated below.

Keesler Medical Center 81MDTS/SGQC Clinical Laboratory Rm 1E326 301 Fisher St Keesler AFB, MS 39534

5.2. The Vendor shall assign a Project Manager to oversee all operations required for successful implementation and execution of the requirement.

5.2.1. The Project Manager will provide a timeline identifying critical points in the delivery/installation phase, wherein Day 0 = Notice of Award.

5.3. No less than 10 calendar days from the contract award, vendor shall coordinate and conduct a post-award site visit for the purpose of coordinating the schedule for equipment installation and validations.

5.3.1. Vendor must include Utility layout required and CAD drawing with detailed analyzer layout with proposal.

(See current layout – attachment 1).

5.4. Contract must include instrument installation, set-up, validation, supplies, and labor. Instruments must be installed, validated and ready for patient testing by the start of the base year of the period of performance. The on-site installation process should begin no less than 90 days after award, but as soon as necessary to ensure equipment is fully operational on first day of the base year of the period of performance. This includes all correlation, precision, linearity, normal ranges, and any other required validation studies by a vendor provided Clinical Application Specialist. The Clinical Application Specialist should possess a thorough knowledge of method validation/verification and, where applicable, is familiar with the use of clinical laboratory statistical evaluation software (e.g. EP Evaluator®). The assigned Clinical Application Specialist will be responsible for the entire method validation. The completed validation studies and raw data must be provided to the Hematology management staff electronically and, in a binder, at least 3 weeks prior to analyzer functionality.

5.5. Method validation/verification will be conducted in accordance with CLIA regulations and CAP standards.

5.6. The method validation/verification will be completed and approved by the Laboratory Director prior to reporting of patient results. Payment for services will not begin until the analyzer system has been approved for reporting of patient results.

5.7. All instrument reagents, calibrators, linearity materials and other required reagents/materials used in the method validation/verification study will be provided by the Vendor at no additional cost to the Government. Assay lots will be quality checked upon delivery. Vendor’s customer samples may also be used. These materials will not be used in the analysis of specimens for patient care.

ATTACHMENT 1

ADDENDUM TO 52.212-1

ADDENDUM TO 52.212-1

Volume I. Administrative

Provide the following items:

o Completed SF 1449: Blocks 12, 17 (to include CAGE code and UEI number), 30a.-c.

o Point of Contact Information (Name, Telephone Number, Fax Number, and Email) o Statement that the offeror will hold its quote firm for at least 180 days from the due date for receipt of quotes, subject to any changes that may occur as a result of discussions, if applicable.

Potential contractors must be registered in the System for Award Management (SAM) to be eligible for award. The SAM website is http://www.sam.gov. Offers are due by 16 June 2025, 13:00 PM, Central Standard Time. The deadline for questions is on 5 June 2025 , 13:00 PM, Central Standard Time. All questions must be submitted in writing to carolynn.j.benn.civ@health.mil and david.k.erpelding.civ@health.mil Offers shall be submitted via e-mail to the same emails as well.

Please provide completed provisions, as listed in the solicitation. Alternately, complete all provisions in SAM and provide confirmation of completion with offer.

Volume II. Technical Capability

Factor 1. Technical Capability. Offerors shall demonstrate how their proposed items comply with the Government's Statement of Objectives via the submission of a written capability statement, product literature, or other materials, to include proof where applicable (e.g., Food and Drug Administration approval of equipment and assays).

Offerors shall separately address each paragraph AND subparagraph within the Statement of Objectives.

Failure to separately address each paragraph will be construed to mean the offeror is unable to meet that the requirements of that particular paragraph and would thus not be eligible for award.

Subfactor 1A. Authorization to Operate (ATO)

Subfactor 1B. Instruments/Equipment and Reagents/Consumables

Subfactor 1C. Service and Maintenance

Subfactor 1D. Training

Subfactor 1E. Delivery and Installation

Volume III. Price.

Factor 2. Price. The Offeror shall submit pricing for all contract line-item numbers (CLIN) identified in the solicitation using the provided Excel Pricing Worksheet, Attachment #3. The Pricing Worksheet requires unit pricing for each test which is multiplied by the annual quantities provided in the SOO. The Pricing Worksheet’s CLIN total will be divided by 12 to derive the firm-fixed monthly unit price on the resultant contract.

The quantities listed herein are the Government’s best estimate of its needs for the five-year performance period and are based on historical data and future projected usage. The final unit prices for each test established in any contract resulting from this solicitation are final. The Government will pay a firm-fixed price per month based on the estimated quantities provided. Actual number of tests (i.e., equivalent reagents) ordered and accepted, may fluctuate monthly but shall not exceed the annual quantities provided. In the event the Government needs additional results, Attachment 3 will provide the basis for pricing any modification for additional results. Therefore, the offeror is hereby informed that the final awarded unit (i.e., test) prices are not subject to adjustment on the basis of a difference between test quantities estimated on the solicitation, quantities established on the contract, and actual quantities used.

Certified Cost or Pricing Data is not required for commercial items; but, if only one quote is received, Other than Certified Cost or Pricing Data may be required.

This is an "all or none" solicitation. Failure to provide a quote for any CLIN, unless it is specifically identified as "not separately priced" within the quote, will be construed to mean the offeror is not quoting that CLIN and thus, not eligible for award.

(End of provision)

ITEM NO SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

0001 12 Months Coagulation - CPRR

FFP

The successful offeror shall furnish all equipment, reagents, consumables, controls, and any necessary services (e.g., maintenance of furnished equipment) to the Clinical Laboratory, Keesler Medical Center, Keesler AFB, Mississippi for the purpose of Coagulation testing under a Cost-per-Reportable Result (CPRR) Agreement.

The monthly unit price will be a firm-fixed price based on the estimates provided in the Statement of Objectives.

Period of Performance: 1 October 2025 - 30 September 2026 NOTE: The requirements in DFARS 252.211-7003, Item Identification and Valuation, are applicable for this line item. The contractor shall provide DoD unique identification or a DoD recognized unique identification equivalent.

FOB: Destination

NET AMT

0002 1 Job Installation/Validation

FFP

Initial Installation and validation of equipment.

1001 12 Months OPTION Coagulation - CPRR

FFP

The successful offeror shall furnish all equipment, reagents, consumables, controls, and any necessary services (e.g., maintenance of furnished equipment) to the Clinical Laboratory, Keesler Medical Center, Keesler AFB, Mississippi for the purpose of Coagulation testing under a Cost-per-Reportable Result (CPRR) Agreement.

The monthly unit price will be a firm-fixed price based on the estimates provided in the Statement of Objectives.

Period of Performance: 1 October 2025 - 30 September 2026 NOTE: The requirements in DFARS 252.211-7003, Item Identification and Valuation, are applicable for this line item. The contractor shall provide DoD unique identification or a DoD recognized unique identification equivalent.

2001 12 Months OPTION Coagulation - CPRR

FFP

The successful offeror shall furnish all equipment, reagents, consumables, controls, and any necessary services (e.g., maintenance of furnished equipment) to the Clinical Laboratory, Keesler Medical Center, Keesler AFB, Mississippi for the purpose of Coagulation testing under a Cost-per-Reportable Result (CPRR) Agreement.

The monthly unit price will be a firm-fixed price based on the estimates provided in the Statement of Objectives.

Period of Performance: 1 October 2025 - 30 September 2026 NOTE: The requirements in DFARS 252.211-7003, Item Identification and Valuation, are applicable for this line item. The contractor shall provide DoD unique identification or a DoD recognized unique identification equivalent.

3001 12 Months OPTION Coagulation - CPRR

FFP

The successful offeror shall furnish all equipment, reagents, consumables, controls, and any necessary services (e.g., maintenance of furnished equipment) to the Clinical Laboratory, Keesler Medical Center, Keesler AFB, Mississippi for the purpose of Coagulation testing under a Cost-per-Reportable Result (CPRR) Agreement.

The monthly unit price will be a firm-fixed price based on the estimates provided in the Statement of Objectives.

Period of Performance: 1 October 2025 - 30 September 2026 NOTE: The requirements in DFARS 252.211-7003, Item Identification and Valuation, are applicable for this line item. The contractor shall provide DoD unique identification or a DoD recognized unique identification equivalent.

4001 12 Months OPTION Coagulation - CPRR

FFP

The successful offeror shall furnish all equipment, reagents, consumables, controls, and any necessary services (e.g., maintenance of furnished equipment) to the Clinical Laboratory, Keesler Medical Center, Keesler AFB, Mississippi for the purpose of Coagulation testing under a Cost-per-Reportable Result (CPRR) Agreement.

The monthly unit price will be a firm-fixed price based on the estimates provided in the Statement of Objectives.

Period of Performance: 1 October 2025 - 30 September 2026 NOTE: The requirements in DFARS 252.211-7003, Item Identification and Valuation, are applicable for this line item. The contractor shall provide DoD unique identification or a DoD recognized unique identification equivalent.

INSPECTION AND ACCEPTANCE TERMS

Supplies/services will be inspected/accepted at:

CLIN INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY

0001 N/A N/A N/A Government 0002 N/A N/A N/A Government 1001 N/A N/A N/A Government 2001 N/A N/A N/A Government 3001 N/A N/A N/A Government 4001 N/A N/A N/A Government

DELIVERY INFORMATION

CLIN DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC /

CAGE

0001 30-SEP-2026 12 PROFESSIONAL CONTRACTS MEDICAL

LEN VAN SITTERT

AF BPN NO MILSBILLS PROCESSES

301 FISHER ST RM 1A132 BLDG 468 5TH

KEESLER AFB MS

228-376-5000

F2J4PC

0002 30-SEP-2026 1 (SAME AS PREVIOUS LOCATION)

1001 30-SEP-2027 12 (SAME AS PREVIOUS LOCATION)

2001 30-SEP-2028 12 (SAME AS PREVIOUS LOCATION)

3001 30-SEP-2029 12 (SAME AS PREVIOUS LOCATION)

4001 30-SEP-2030 12 (SAME AS PREVIOUS LOCATION)

CLAUSES INCORPORATED BY REFERENCE

52.203-3 Gratuities APR 1984 52.203-6 Alt I Restrictions On Subcontractor Sales To The Government

(JUN 2020) -- Alternate I

NOV 2021

52.203-11 Certification and Disclosure Regarding Payments to Influence Certain Federal Transactions

SEP 2024

52.203-12 Limitation On Payments To Influence Certain Federal Transactions

JUN 2020

52.204-7 System for Award Management NOV 2024 52.204-13 System for Award Management Maintenance OCT 2018 52.204-16 Commercial and Government Entity Code Reporting AUG 2020 52.204-18 Commercial and Government Entity Code Maintenance AUG 2020 52.204-21 Basic Safeguarding of Covered Contractor Information

Systems

NOV 2021

52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment

NOV 2021

52.204-29 Federal Acquisition Supply Chain Security Act Orders-- Representation and Disclosures.

DEC 2023

52.209-10 Prohibition on Contracting With Inverted Domestic Corporations

NOV 2015

52.212-1 Instructions to Offerors--Commercial Products and Commercial Services

SEP 2023

52.212-4 Contract Terms and Conditions--Commercial Products and Commercial Services

NOV 2023

52.217-5 Evaluation Of Options JUL 1990 52.222-22 Previous Contracts And Compliance Reports FEB 1999 52.223-5 Pollution Prevention and Right-to-Know Information MAY 2024

52.229-11 Tax on Certain Foreign Procurements--Notice and Representation

JUN 2020

52.229-12 Tax on Certain Foreign Procurements FEB 2021 52.232-39 Unenforceability of Unauthorized Obligations JUN 2013 252.203-7000 Requirements Relating to Compensation of Former DoD

Officials

SEP 2011

252.203-7002 Requirement to Inform Employees of Whistleblower Rights DEC 2022 252.203-7005 Representation Relating to Compensation of Former DoD

Officials

SEP 2022

252.204-7003 Control Of Government Personnel Work Product APR 1992 252.204-7012 Safeguarding Covered Defense Information and Cyber

Incident Reporting

MAY 2024

252.204-7016 Covered Defense Telecommunications Equipment or Services -- Representation

DEC 2019

252.204-7017 Prohibition on the Acquisition of Covered Defense Telecommunications Equipment or Services -- Representation

MAY 2021

252.204-7018 Prohibition on the Acquisition of Covered Defense Telecommunications Equipment or Services

JAN 2023

252.204-7024 Notice on the Use of the Supplier Performance Risk System MAR 2023 252.223-7008 Prohibition of Hexavalent Chromium JAN 2023 252.225-7012 Preference For Certain Domestic Commodities APR 2022 252.225-7055 Representation Regarding Business Operations with the

Maduro Regime

MAY 2022

252.225-7056 Prohibition Regarding Business Operations with the Maduro Regime

JAN 2023

252.225-7060 Prohibition on Certain Procurements from the Xinjiang Uyghur Autonomous Region

JUN 2023

252.226-7001 Utilization of Indian Organizations, Indian-Owned Economic Enterprises, and Native Hawaiian Small Business Concerns

JAN 2023

252.232-7003 Electronic Submission of Payment Requests and Receiving Reports

DEC 2018

252.232-7010 Levies on Contract Payments DEC 2006 252.243-7002 Requests for Equitable Adjustment DEC 2022 252.244-7000 Subcontracts for Commercial Products or Commercial

Services

NOV 2023

252.247-7023 Transportation of Supplies by Sea OCT 2024

CLAUSES INCORPORATED BY FULL TEXT

52.204-17 OWNERSHIP OR CONTROL OF OFFEROR (AUG 2020)

(a) Definitions. As used in this provision--

Commercial and Government Entity (CAGE) code means—

(1) An identifier assigned to entities located in the United States or its outlying areas by the Defense Logistics Agency (DLA) Commercial and Government Entity (CAGE) Branch to identify a commercial or government entity by unique location; or

(2) An identifier assigned by a member of the North Atlantic Treaty Organization (NATO) or by the NATO Support and Procurement Agency (NSPA) to entities located outside the United States and its outlying areas that the DLA Commercial and Government Entity (CAGE) Branch records and maintains in the CAGE master file. This type of code is known as a NATO CAGE (NCAGE) code.

Highest-level owner means the entity that owns or controls an immediate owner of the offeror, or that owns or controls one or more entities that control an immediate owner of the offeror. No entity owns or exercises control of the highest level owner.

Immediate owner means an entity, other than the offeror, that has direct control of the offeror. Indicators of control include, but are not limited to, one or more of the following: Ownership or interlocking management, identity of interests among family members, shared facilities and equipment, and the common use of employees.

(b) The Offeror represents that it [ ___ ] has or [ ___ ] does not have an immediate owner. If the Offeror has more than one immediate owner (such as a joint venture), then the Offeror shall respond to paragraph (c) and if applicable, paragraph (d) of this provision for each participant in the joint venture.

(c) If the Offeror indicates ``has'' in paragraph (b) of this provision, enter the following information:

Immediate owner CAGE code:

Immediate owner legal name: ___

(Do not use a ``doing business as'' name)

Is the immediate owner owned or controlled by another entity?:

[ ___ ] Yes or [ ___ ] No.

(d) If the Offeror indicates ``yes'' in paragraph (c) of this provision, indicating that the immediate owner is owned or controlled by another entity, then enter the following information:

Highest-level owner CAGE code:

Highest-level owner legal name:

(Do not use a ``doing business as'' name)

52.204-20 Predecessor of Offeror (AUG 2020)

(a) Definitions. As used in this provision--

Commercial and Government Entity (CAGE) code means--

(1) An identifier assigned to entities located in the United States or its outlying areas by the Defense Logistics Agency (DLA) Commercial and Government Entity (CAGE) Branch to identify a commercial or government entity by unique location; or

(2) An identifier assigned by a member of the North Atlantic Treaty Organization (NATO) or by the NATO Support and Procurement Agency (NSPA) to entities located outside the United States and its outlying areas that the DLA Commercial and Government Entity (CAGE) Branch records and maintains in the CAGE master file. This type of code is known as a NATO CAGE (NCAGE) code.

Predecessor means an entity that is replaced by a successor and includes any predecessors of the predecessor.

Successor means an entity that has replaced a predecessor by acquiring the assets and carrying out the affairs of the predecessor under a new name (often through acquisition or merger). The term “successor” does not include new offices/divisions of the same company or a company that only changes its name. The extent of the responsibility of the successor for the liabilities of the predecessor may vary, depending on State law and specific circumstances.

(b) The Offeror represents that it [____] is or [____] is not a successor to a predecessor that held a Federal contract or grant within the last three years.

(c) If the Offeror has indicated “is” in paragraph (b) of this provision, enter the following information for all predecessors that held a Federal contract or grant within the last three years (if more than one predecessor, list in reverse chronological order):

Predecessor CAGE code: ____ (or mark “Unknown”).

Predecessor legal name: ____.

(Do not use a “doing business as” name).

52.204-26 COVERED TELECOMMUNICATIONS EQUIPMENT OR SERVICES--REPRESENTATION (OCT

2020)

(a) Definitions. As used in this provision, “covered telecommunications equipment or services” and "reasonable inquiry" have the meaning provided in the clause 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment.

(b) Procedures. The Offeror shall review the list of excluded parties in the System for Award Management (SAM) (https://www.sam.gov) for entities excluded from receiving federal awards for “covered telecommunications equipment or services”.

(c) Representations.

(1) The Offeror represents that it [ ___ ] does, [ ___ ] does not provide covered telecommunications equipment or services as a part of its offered products or services to the Government in the performance of any contract, subcontract, or other contractual instrument.

(2) After conducting a reasonable inquiry for purposes of this representation, the offeror represents that it [ ___ ] does, [ ___ ] does not use covered telecommunications equipment or services, or any equipment, system, or service that uses covered telecommunications equipment or services.

52.212-2 EVALUATION – COMMERCIAL ITEMS

Evaluation—Commercial Products and Commercial Services (Nov 2021)

(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:

Paragraph (a) is hereby replaced by the following:

Award will be made using lowest price technically acceptable (LPTA) through FAR Part 13 simplified acquisition procedures. Award will be made to the responsible offeror on the basis of the lowest evaluated price of offers meeting or exceeding the acceptability standards for non-cost factors. Award may be made without discussions with offerors (except communications conducted for the purpose of minor clarification). Therefore, each initial offer should contain the offeror’s best terms from a technical and price standpoint. However, the Government reserves the right to conduct discussions if it is later determined by the contracting officer to be necessary. Award will be made on an all or none basis.

1.Technical Capability. The following adjectival ratings will be used in evaluating the offeror’s technical capability:

Acceptable – An Acceptable rating will be assessed on any offeror whose quote clearly meets each aspect of the Statement of Objectives and other requirements listed in the solicitation.

Unacceptable – An Unacceptable rating will be assessed on any offeror that presents a quote that demonstrates any of the following:

a) Failure to meet each aspect of the Statement of Objectives and other requirement of the solicitation.

b) Failure to provide sufficient detail for the Government to determine whether its offer meets the Statement of Objectives and the requirements of the solicitation.

c) Failure to provide all of the tests required in the solicitation.

Authorization to Operate Capability:

As part of the Technical Capability Evaluation above, evaluation of an Offeror’s ability to acquire an Authorization to Operate (ATO) will be based on the attached ATO form, which will be filled out in its entirety. The evaluation will be based on the Offeror’s capability to obtain approval for an ATO. This evaluation criteria will be rated as follows:

Acceptable – An Acceptable rating will be assessed on any Offerors whose completed form provides the Government with a high confidence that an ATO will be approved.

Unacceptable -An Unacceptable rating will be assessed on any Offerors whose completed form provides the Government with a low confidence that an ATO will be approved.

2. Price. Pricing must be determined to be fair and reasonable prior to award.

(b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s).

(c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.

52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS--COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (MAY 2024) ALTERNATE I (FEB 2024)

The Offeror shall complete only paragraph (b) of this provision if the Offeror has completed the annual representations and certification electronically in the System for Award Management (SAM) accessed through https://www.sam.gov. If the Offeror has not completed the annual representations and certifications electronically, the Offeror shall complete only paragraphs (c) through (v) of this provision.

(a) Definitions. As used in this provision --

"Covered telecommunications equipment or services" has the meaning provided in the clause 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment.

"Economically disadvantaged women-owned small business (EDWOSB) concern" means a small business concern that is at least 51 percent directly and unconditionally owned by, and the management and daily business operations of which are controlled by, one or more women who are citizens of the United States and who are economically disadvantaged in accordance with 13 CFR part 127, and the concern is certified by SBA or an approved third-party certifier in accordance with 13 CFR 127.300. It automatically qualifies as a women-owned small business eligible under the WOSB Program.

"Forced or indentured child labor" means all work or service-

(1) Exacted from any person under the age of 18 under the menace of any penalty for its nonperformance and for which the worker does not offer himself voluntarily; or

(2) Performed by any person under the age of 18 pursuant to a contract the enforcement of which can be accomplished by process or penalties.

"Highest-level owner" means the entity that owns or controls an immediate owner of the offeror, or that owns or controls one or more entities that control an immediate owner of the offeror. No entity owns or exercises control of the highest level owner.

"Immediate owner" means an entity, other than the offeror, that has direct control of the offeror. Indicators of control include, but are not limited to, one or more of the following: Ownership or interlocking management, identity of interests among family members, shared facilities and equipment, and the common use of employees.

"Inverted domestic corporation" means a foreign incorporated entity that meets the definition of an inverted domestic corporation under 6 U.S.C. 395(b), applied in accordance with the rules and definitions of 6 U.S.C. 395(c).

"Manufactured end product" means any end product in product and service codes (PSCs) 1000-9999, except--

(1) PSC 5510, Lumber and Related Basic Wood Materials;

(2) Product or Service Group (PSG) 87, Agricultural Supplies;

(3) PSG 88, Live Animals;

(4) PSG 89, Subsistence;

(5) PSC 9410, Crude Grades of Plant Materials;

(6) PSC 9430, Miscellaneous Crude Animal Products, Inedible;

(7) PSC 9440, Miscellaneous Crude Agricultural and Forestry Products;

(8) PSC 9610, Ores;

(9) PSC 9620, Minerals, Natural and Synthetic; and

(10) PSC 9630, Additive Metal Materials.

"Place of manufacture" means the place where an end product is assembled out of components, or otherwise made or processed from raw materials into the finished product that is to be provided to the Government. If a product is disassembled and reassembled, the place of reassembly is not the place of manufacture.

"Predecessor" means an entity that is replaced by a successor and includes any predecessors of the predecessor.

"Reasonable inquiry" has the meaning provided in the clause 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment.

"Restricted business operations" means business operations in Sudan that include power production activities, mineral extraction activities, oil-related activities, or the production of military equipment, as those terms are defined in the Sudan Accountability and Divestment Act of 2007 (Pub. L. 110-174). Restricted business operations do not include business operations that the person (as that term is defined in Section 2 of the Sudan Accountability and Divestment Act of 2007) conducting the business can demonstrate--

(1) Are conducted under contract directly and exclusively with the regional government of southern Sudan;

(2) Are conducted pursuant to specific authorization from the Office of Foreign Assets Control in the Department of the Treasury, or are expressly exempted under Federal law from the requirement to be conducted under such authorization;

(3) Consist of providing goods or services to marginalized populations of Sudan;

(4) Consist of providing goods or services to an internationally recognized peacekeeping force or humanitarian organization;

(5) Consist of providing goods or services that are used only to promote health or education; or

(6) Have been voluntarily suspended.

"Sensitive technology"--

(1) Means hardware, software, telecommunications equipment, or any other technology that is to be used specifically--

(i) To restrict the free flow of unbiased information in Iran; or

(ii) To disrupt, monitor, or otherwise restrict speech of the people of Iran; and

(2) Does not include information or informational materials the export of which the President does not have the authority to regulate or prohibit pursuant to section 203(b)(3) of the International Emergency Economic Powers Act (50 U.S.C. 1702(b)(3)).

"Service-disabled veteran-owned small business (SDVOSB) concern" means a small business concern--

(1)(i) Not less than 51 percent of which is owned and controlled by one or more service-disabled veterans or, in the case of any publicly owned business, not less than 51 percent of the stock of which is owned by one or more service-disabled veterans; and

(ii) The management and daily business operations of which are controlled by one or more service-disabled veterans or, in the case of a service-disabled veteran with permanent and severe disability, the spouse or permanent caregiver of such veteran; or

(2) A small business concern eligible under the SDVOSB Program in accordance with 13 CFR part 128 (see subpart 19.14).

(3) Service-disabled veteran, as used in this definition, means a veteran as defined in 38 U.S.C. 101(2), with a disability that is service-connected, as defined in 38 U.S.C. 101(16), and who is registered in the Beneficiary Identification and Records Locator Subsystem, or successor system that is maintained by the Department of Veterans Affairs' Veterans Benefits Administration, as a service-disabled veteran.

"Service-disabled veteran-owned small business (SDVOSB) concern eligible under the SDVOSB Program" means an SDVOSB concern that--

(1) Effective January 1, 2024, is designated in the System for Award Management (SAM) as certified by the Small Business Administration (SBA) in accordance with 13 CFR 128.300; or

(2) Has represented that it is an SDVOSB concern in SAM and submitted a complete application for certification to SBA on or before December 31, 2023.

"Service-disabled veteran-owned small business (SDVOSB) Program" means a program that authorizes contracting officers to limit competition, including award on a sole-source basis, to SDVOSB concerns eligible under the SDVOSB Program.

"Small business concern"--

(1) Means a concern, including its affiliates, that is independently owned and operated, not dominant in its field of operation, and qualified as a small business under the criteria in 13 CFR part 121 and size standards in this solicitation.

(2) Affiliates, as used in this definition, means business concerns, one of whom directly or indirectly controls or has the power to control the others, or a third party or parties control or have the power to control the others. In determining whether affiliation exists, consideration is given to all appropriate factors including common ownership, common management, and contractual relationships. SBA determines affiliation based on the factors set forth at 13

CFR 121.103.

"Small disadvantaged business concern, consistent with 13 CFR 124.1001", means a small business concern under the size standard applicable to the acquisition, that--

(1) Is at least 51 percent unconditionally and directly owned (as defined at 13 CFR 124.105) by--

(i) One or more socially disadvantaged (as defined at 13 CFR 124.103) and economically disadvantaged (as defined at 13 CFR 124.104) individuals who are citizens of the United States; and

(ii) Each individual claiming economic disadvantage has a net worth not exceeding the threshold at 13 CFR 124.104(c)(2) after taking into account the applicable exclusions set forth at 13 CFR 124.104(c)(2); and

(2) The management and daily business operations of which are controlled (as defined at 13 CFR 124.106) by individuals, who meet the criteria in paragraphs (1)(i) and (ii) of this definition.

"Subsidiary" means an entity in which more than 50 percent of the entity is owned--

(1) Directly by a parent corporation; or

(2) Through another subsidiary of a parent corporation.

"Successor" means an entity that has replaced a predecessor by acquiring the assets and carrying out the affairs of the predecessor under a new name (often through acquisition or merger). The term "successor" does not include new offices/divisions of the same company or a company that only changes its name. The extent of the responsibility of the successor for the liabilities of the predecessor may vary, depending on State law and specific circumstances.

"Veteran-owned small business concern" means a small business concern--

(1) Not less than 51 percent of which is owned and controlled by one or more veterans (as defined at 38 U.S.C.

101(2)) or, in the case of any publicly owned business, not less than 51 percent of the stock of which is owned by one or more veterans; and

(2) The management and daily business operations of which are controlled by one or more veterans.

"Women-owned business concern" means a concern which is at least 51 percent owned by one or more women; or in the case of any publicly owned business, at least 51 percent of its stock is owned by one or more women; and whose management and daily business operations are controlled by one or more women.

"Women-owned small business concern" means a small business concern--

(1) That is at least 51 percent owned by one or more women; or, in the case of any publicly owned business, at least 51 percent of the stock of which is owned by one or more women; and

(2) Whose management and daily business operations are controlled by one or more women.

"Women-owned small business (WOSB) concern eligible under the WOSB Program" (in accordance with 13 CFR part 127), means a small business concern that is at least 51 percent directly and unconditionally owned by, and the management and daily business operations of which are controlled by, one or more women who are citizens of the United States, and the concern is certified by SBA or an approved third-party certifier in accordance with 13 CFR 127.300.

(b) (1) Annual Representations and Certifications. Any changes provided by the Offeror in paragraph (b)(2) of this provision do not automatically change the representations and certifications in SAM.

(2) The offeror has completed the annual representations and certifications electronically in SAM accessed through http://www.sam.gov. After reviewing SAM information, the Offeror verifies by submission of this offer that the representations and certifications currently posted electronically at FAR 52.212-3, Offeror Representations and Certifications--Commercial Products and Commercial Services, have been entered or updated in the last 12 months, are current, accurate, complete, and applicable to this solicitation (including the business size standard(s) applicable to the NAICS code(s) referenced for this solicitation), at the time this offer is submitted and are incorporated in this offer by reference (see FAR 4.1201), except for paragraphs ___

[Offeror to identify the applicable paragraphs at (c) through (v) of this provision that the offeror has completed for the purposes of this solicitation only, if any.

These amended representation(s) and/or certification(s) are also incorporated in this offer and are current, accurate, and complete as of the date of this offer.

Any changes provided by the offeror are applicable to…